Author

Tomoki Sekiya

Institutions: Niigata University Medical and Dental Hospital, Niigata University

Observed institutions: Niigata University Medical and Dental Hospital, Niigata University

OpenAlex ID: A5114046181

Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501)

2022 · Satoshi Watanabe, Kazuko Sakai, et al. · Cancers · 14

Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients

2020 · Riuko Ohashi, Hajime Umezu, et al. · Cells · 9

Abstract 5263: The impact of MRTX1133 on anti-tumor immunity in lung cancer with KRASG12D mutation

2024 · Kunihiro Shono, Satoshi Watanabe, et al. · Cancer Research · 4

Nintedanib enhances the antitumor efficacy of pd-1 blockade, potentially through inhibition of myeloid-derived suppressor cells and cancer-associated fibroblasts

2026 · Ryo Suzuki, Satoshi Watanabe, et al. · Cancer Immunology Immunotherapy · 1

Lung adenocarcinoma with rapid progression and fatal outcome through spread through air spaces: an autopsy case report

2026 · Jun Arinami, Yu Saida, et al. · Translational Lung Cancer Research

Abstract 3848: Comprehensive protein analysis to identify the proteins responsible for sarcopenia and their impact on antitumor immunotherapy in non-small cell lung cancer

2024 · Takaaki Masuda, Satoshi Watanabe, et al. · Cancer Research

Abstract 4064: PD-1 blockade therapy enhances the antitumor effects of lymphodepletion and adoptive T cell transfer

2023 · Satoshi Watanabe, Miho Takahashi, et al. · Cancer Research

Abstract 5068: Nintedanib enhances antitumor effects of anti-PD-1 therapies through inhibition of immunosuppressive cells in tumor microenvironment

2023 · Ryo Suzuki, Satoshi Watanabe, et al. · Cancer Research

DDX3X mediates EGFR-TKI resistance through VEGFR signaling

2021 · Aya Ohtsubo, Hiroshi Kagamu, et al. · Research Square

Nintedanib suppresses myeloid-derived suppressor cells and enhances antitumor effects of PD-1 blockade therapy

2020 · Ryo Suzuki, Watanabe Satoshi, et al. · 日本癌学会学術総会抄録集(Web)

Works count: 10

Citation count: 28

H-index: 3

I10-index: 1